| Marsha Hardman-lundell, LCSW | |
|
100 N Medical Dr, Slc, UT 84113-1103 | |
| (801) 588-2000 | |
| Not Available |
| Full Name | Marsha Hardman-lundell |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 100 N Medical Dr, Slc, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245248368 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 92-138935-3501 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Marsha Hardman-lundell, LCSW 100 N Medical Dr, Slc, UT 84113-1103 Ph: (801) 588-2000 | Marsha Hardman-lundell, LCSW 100 N Medical Dr, Slc, UT 84113-1103 Ph: (801) 588-2000 |
News Archive
The April 2021 issue of JNCCN-;Journal of the National Comprehensive Cancer Network publishes new research from Memorial Sloan Kettering Cancer Center (MSK) and Gustave Roussy Institute, which suggests that baseline brain imaging should be considered in most patients with metastatic kidney cancer.
Biomet received a Warning Letter from the U.S. Food and Drug Administration (FDA) regarding the Signature™ Personalized Patient Care system, alleging that Biomet does not have appropriate clearance or approval to market the system in the United States.
Researchers at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, Missouri, a national leader in the early adoption and use of advanced treatments for cancer patients, will soon become the first in the world to test an innovative radiotherapy system from ViewRay, Inc. The ViewRay system is designed to improve the accuracy of cancer treatments through a combination of medical imaging and radiotherapy delivery.
Inflammatory breast cancer is a very aggressive type of cancer associated with early metastasis and poor survival rates, and the prognosis is even worse for patients with tumors expressing the ErbB2 receptor. The ErbB2-inhibiting drug lapatinib can slow the spread of cancer cells in individuals with advanced breast cancer who have already tried other chemotherapy medications.
Evidence continues to build that lifestyle modifications help control blood pressure (BP) levels. Data evaluating the consumption of coffee and alcohol and the impact of low fitness levels will be presented at the American Society of Hypertension, Inc.'s 26th Annual Scientific Meeting and Exposition (ASH 2011) and will be featured in the May 22 ASH press briefing.
› Verified 2 days ago
Ms. Kristin Allison Midyett, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 501 E Chipeta Way, Slc, UT 84108 Phone: 801-587-3000 | |
Joellyn Orcutt Manville, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 275 E South Temple, Ste 202, Slc, UT 84111 Phone: 801-609-1055 Fax: 801-953-0271 | |
Elizabeth Mccooey, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 370 E South Temple Ste 550, Slc, UT 84111 Phone: 385-212-4195 | |
Amy H Oxman, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 100 N Medical Dr, Slc, UT 84113 Phone: 801-588-2000 | |
Kayleen Savage Davidson, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 344 E 100 S Ste 301, Slc, UT 84111 Phone: 801-322-4257 | |
Christy Atkinson, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 525 E 100 S, Suite 120, Slc, UT 84102 Phone: 801-389-9997 |